Director Liu Tong Tony files Form 3 at China SXT (SXTC)

Rhea-AI Filing Summary

China SXT Pharmaceuticals, Inc. director Liu Tong Tony has filed a Form 3, which is the initial statement of beneficial ownership of the company’s securities. This filing formally records his status as a reporting person and establishes the baseline for any future insider transaction disclosures.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"Form 3 is the initial statement of beneficial ownership of securities."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Initial statement of beneficial ownership of the company’s securities."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"This filing formally records his status as a reporting person."

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Tong Tony

(Last) (First) (Middle)

26TH BUILDING, BIGUIYUAN

HAILING DISTRICT

(Street)

TAIZHOU JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/10/2022

3. Issuer Name and Ticker or Trading Symbol
China SXT Pharmaceuticals, Inc. [ SXTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Tong Liu	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the China SXT (SXTC) Form 3 filing by Liu Tong Tony represent?

The Form 3 for China SXT (SXTC) is Liu Tong Tony’s initial statement of beneficial ownership. It formally identifies him as a director and reporting person, creating a baseline from which any future insider trades or holdings changes will be reported under SEC rules.

Does the China SXT (SXTC) Form 3 show any insider trades by Liu Tong Tony?

No trades are reported in this Form 3 for China SXT (SXTC). The transactions section and summary counts are all zero, indicating this filing only establishes initial beneficial ownership status rather than disclosing any purchase, sale, or other insider transaction.

What role does Liu Tong Tony have at China SXT Pharmaceuticals (SXTC)?

Liu Tong Tony is identified as a director of China SXT Pharmaceuticals (SXTC). As a director, he is considered an insider under SEC rules and must report his beneficial ownership positions and any subsequent changes through Forms 3, 4, and 5 as applicable.

Are there any derivative securities reported in this China SXT (SXTC) Form 3?

The Form 3 for China SXT (SXTC) shows no derivative securities. The derivative summary is empty and derivative transaction counts are zero, indicating no options, warrants, or similar derivative positions are disclosed in this particular filing excerpt.

Does the China SXT (SXTC) Form 3 indicate buying or selling direction by the insider?

The Form 3 for China SXT (SXTC) does not indicate any buying or selling direction. Transaction counts for buys, sells, acquisitions, and dispositions are all zero, so the filing functions purely as an initial ownership statement without reporting active trading activity.